|
1
|
Krützfeldt J, Rajewsky N, Braich R, et al:
Silencing of microRNAs in vivo with ‘antagomirs’. Nature.
438:685–689. 2005.
|
|
2
|
Meister G, Landthaler M, Dorsett Y and
Tuschl T: Sequence-specific inhibition of microRNA- and
siRNA-induced RNA silencing. RNA. 3:544–550. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ørom UA, Kauppinen S and Lund AH:
LNA-modified oligonucleotides mediate specific inhibition of
microRNA function. Gene. 372:137–141. 2006.PubMed/NCBI
|
|
4
|
Ebert MS, Neilson JR and Sharp PA:
MicroRNA sponges: competitive inhibitors of small RNAs in mammalian
cells. Nat Methods. 9:721–726. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ebert MS and Sharp PA: MicroRNA sponges:
progress and possibilities. RNA. 16:2043–2050. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Valastyan S, Reinhardt F, Benaich N, et
al: A pleiotropically acting microRNA, miR-31, inhibits breast
cancer metastasis. Cell. 137:1032–1046. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lin J, Teo S, Lam DH, Jeyaseelan K and
Wang S: MicroRNA-10b pleiotropically regulates invasion,
angiogenicity and apoptosis of tumor cells resembling mesenchymal
subtype of glioblastoma multiforme. Cell Death Dis. 3:e3982012.
View Article : Google Scholar
|
|
8
|
Zhang H, Hao Y, Yang J, et al: Genome-wide
functional screening of miR-23b as a pleiotropic modulator
suppressing cancer metastasis. Nat Commun. 2:5542011. View Article : Google Scholar
|
|
9
|
Xu W, Liu M, Peng X, et al: miR-24–3p and
miR-27a-3p promote cell proliferation in glioma cells via
cooperative regulation of MXI1. Int J Oncol. 42:757–766. 2013.
|
|
10
|
Furnari FB, Fenton T, Bachoo RM, et al:
Malignant astrocytic glioma: genetics, biology, and paths to
treatment. Genes Dev. 21:2683–2710. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen L, Han L, Zhang K, et al: VHL
regulates the effects of miR-23b on glioma survival and invasion
via suppression of HIF-1/VEGF and β-catenin/Tcf-4 signaling. Neuro
Oncol. 14:1026–1036. 2012.PubMed/NCBI
|
|
12
|
Ciafrè SA, Galardi S, Mangiola A, et al:
Extensive modulation of a set of microRNAs in primary glioblastoma.
Biochem Biophys Res Commun. 334:1351–1358. 2005.PubMed/NCBI
|
|
13
|
Wang KC, Garmire LX, Young A, et al: Role
of microRNA-23b in flow-regulation of Rb phosphorylation and
endothelial cell growth. Proc Natl Acad Sci USA. 107:3234–3239.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jin L, Wessely O, Marcusson EG, Ivan C,
Calin GA and Alahari SK: Prooncogenic factors miR-23b and miR-27b
are regulated by Her2/Neu, EGF, and TNF-α in breast cancer. Cancer
Res. 73:2884–2896. 2013.PubMed/NCBI
|
|
15
|
Rogler CE, LeVoci L, Ader T, et al:
MicroRNA-23b cluster microRNAs regulate transforming growth
factor-beta/bone morphogenetic protein signaling and liver stem
cell differentiation by targeting Smads. Hepatology. 50:575–584.
2009. View Article : Google Scholar
|
|
16
|
Zhou X, Ren Y, Moore L, et al:
Downregulation of miR-21 inhibits EGFR pathway and suppresses the
growth of human glioblastoma cells independent of PTEN status. Lab
Invest. 90:144–155. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rubinson DA, Dillon CP, Kwiatkowski AV, et
al: A lentivirus-based system to functionally silence genes in
primary mammalian cells, stem cells and transgenic mice by RNA
interference. Nat Genet. 33:401–406. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dull T, Zufferey R, Kelly M, et al: A
third-generation lentivirus vector with a conditional packaging
system. J Virol. 72:8463–8471. 1998.PubMed/NCBI
|
|
19
|
Hutson TE, Davis ID, Machiels JH, et al:
Biomarker analysis and final efficacy and safety results of a phase
II renal cell carcinoma trial with pazopanib (GW786034), a
multi-kinase angiogenesis inhibitor. J Clin Oncol.
158:50462008.
|
|
20
|
Lu Z, Ghosh S, Wang Z and Hunter T:
Downregulation of caveolin-1 function by EGF leads to the loss of
E-cadherin, increased transcriptional activity of β-catenin, and
enhanced tumor cell invasion. Cancer Cell. 4:499–515.
2003.PubMed/NCBI
|
|
21
|
Burk U, Schubert J, Wellner U, et al: A
reciprocal repression between ZEB1 and members of the miR-200
family promotes EMT and invasion in cancer cells. EMBO Rep.
9:582–589. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang L, Zhang ZG, Zhang RL, et al: Matrix
metalloproteinase 2 (MMP2) and MMP9 secreted by
erythropoietin-activated endothelial cells promote neural
progenitor cell migration. J Neurosci. 26:5996–6003. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kota J, Chivukula RR, O’Donnell KA, et al:
Therapeutic microRNA delivery suppresses tumorigenesis in a murine
liver cancer model. Cell. 137:1005–1017. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang J, Han L, Ge Y, et al: miR-221/222
promote malignant progression of glioma through activation of the
Akt pathway. Int J Oncol. 36:913–920. 2010.PubMed/NCBI
|
|
25
|
Geng J, Luo H, Pu Y, et al: Methylation
mediated silencing of miR-23b expression and its role in glioma
stem cells. Neurosci Lett. 528:185–189. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Foxler DE, Bridge KS, James V, et al: The
LIMD1 protein bridges an association between the prolyl
hydroxylases and VHL to repress HIF-1 activity. Nat Cell Biol.
14:201–208. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Schmalhofer O, Brabletz S and Brabletz T:
E-cadherin, β-catenin, and ZEB1 in malignant progression of cancer.
Cancer Metastasis Rev. 28:151–166. 2009.
|
